SIGA Technologies Inc
SIGA6.595USD
+0.135+2.09%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
471.15MCap. mercado
9.71P/E TTM
Más Datos de SIGA Technologies Inc Compañía
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks, vaccines and therapies for emerging infectious diseases, and health preparedness. The Company's lead product is TPOXX, also known as tecovirimat and ST-246, an orally administered and intravenous (IV) formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the United States maintains a supply of TPOXX under Project BioShield. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox. It uses third parties known as contract manufacturing organizations to procure commercial raw materials and supplies, and to manufacture TPOXX.
Información de la empresa
Símbolo de cotizaciónSIGA
Nombre de la empresaSIGA Technologies Inc
Fecha de salida a bolsaSep 09, 1997
Director ejecutivoDr. Diem Nguyen, Ph.D.
Número de empleados46
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 09
Dirección31 East 62Nd Street
CiudadNEW YORK
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal10065
Teléfono12126729100
Sitio Webhttps://www.siga.com/
Símbolo de cotizaciónSIGA
Fecha de salida a bolsaSep 09, 1997
Director ejecutivoDr. Diem Nguyen, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
275.06K
+4.50%
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
191.05K
+12.87%
Mr. Jaymie A. Durnan
Mr. Jaymie A. Durnan
Independent Director
Independent Director
71.87K
+22.83%
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
67.65K
--
Mr. Julian Nemirovsky
Mr. Julian Nemirovsky
Independent Director
Independent Director
56.87K
+30.70%
Gen. (Retd.) John M. (Jack) Keane
Gen. (Retd.) John M. (Jack) Keane
Independent Director
Independent Director
--
--
Suzanne Harnett
Suzanne Harnett
Senior Vice President - Corporate Affairs and Investor Relations
Senior Vice President - Corporate Affairs and Investor Relations
--
--
Mr. Lawrence R. (Larry) Miller
Mr. Lawrence R. (Larry) Miller
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Harold E. Ford, Jr.
Mr. Harold E. Ford, Jr.
Independent Director
Independent Director
--
--
Mr. Joseph W. (Chip) Marshall, III
Mr. Joseph W. (Chip) Marshall, III
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
275.06K
+4.50%
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
191.05K
+12.87%
Mr. Jaymie A. Durnan
Mr. Jaymie A. Durnan
Independent Director
Independent Director
71.87K
+22.83%
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
67.65K
--
Mr. Julian Nemirovsky
Mr. Julian Nemirovsky
Independent Director
Independent Director
56.87K
+30.70%
Gen. (Retd.) John M. (Jack) Keane
Gen. (Retd.) John M. (Jack) Keane
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Canada
5.82M
82.68%
United States
1.22M
17.32%
Europe, Middle East and Africa (EMEA)
0.00
0.00%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 23 de jul
Actualizado: mié., 23 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
MacAndrews & Forbes Holdings, Inc.
33.81%
Lewis (John Latane IV)
7.38%
Hotchkis and Wiley Capital Management, LLC
4.42%
BlackRock Institutional Trust Company, N.A.
4.41%
The Vanguard Group, Inc.
3.48%
Other
46.50%
Accionistas
Accionistas
Proporción
MacAndrews & Forbes Holdings, Inc.
33.81%
Lewis (John Latane IV)
7.38%
Hotchkis and Wiley Capital Management, LLC
4.42%
BlackRock Institutional Trust Company, N.A.
4.41%
The Vanguard Group, Inc.
3.48%
Other
46.50%
Tipos de accionistas
Accionistas
Proporción
Holding Company
33.81%
Investment Advisor
24.00%
Investment Advisor/Hedge Fund
21.61%
Individual Investor
9.60%
Hedge Fund
3.45%
Pension Fund
1.43%
Research Firm
0.90%
Bank and Trust
0.22%
Insurance Company
0.02%
Other
4.96%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
370
67.87M
95.00%
-3.71M
2025Q1
373
68.25M
95.72%
+20.84M
2024Q4
383
67.66M
94.75%
+19.97M
2024Q3
383
69.27M
97.02%
+23.98M
2024Q2
372
66.53M
93.22%
+21.86M
2024Q1
353
41.88M
58.83%
-3.74M
2023Q4
341
41.95M
58.96%
-4.28M
2023Q3
343
42.34M
59.51%
-1.31M
2023Q2
346
70.75M
97.35%
-304.51K
2023Q1
349
70.50M
96.45%
-1.04M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
MacAndrews & Forbes Holdings, Inc.
24.16M
33.81%
--
--
Apr 17, 2025
Lewis (John Latane IV)
5.27M
7.38%
--
--
Apr 17, 2025
Hotchkis and Wiley Capital Management, LLC
3.16M
4.42%
+1.09M
+52.93%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.15M
4.41%
-66.70K
-2.07%
Mar 31, 2025
The Vanguard Group, Inc.
2.48M
3.48%
+10.82K
+0.44%
Mar 31, 2025
AltraVue Capital, LLC.
2.40M
3.36%
-242.57K
-9.19%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.35M
3.29%
+226.82K
+10.67%
Mar 31, 2025
First Wilshire Securities Management, Inc.
1.59M
2.22%
-787.49K
-33.17%
Mar 31, 2025
American Century Investment Management, Inc.
1.37M
1.92%
+98.69K
+7.76%
Mar 31, 2025
Citadel Advisors LLC
1.16M
1.62%
+108.91K
+10.35%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Cambria Micro and SmallCap Shareholder Yield ETF
1.07%
Acquirers Small and Micro Deep Value ETF
1.04%
Lattice Hartford Multifactor Small Cap ETF
0.61%
Invesco NASDAQ Future Gen 200 ETF
0.49%
First Trust Dow Jones Select MicroCap Index Fund
0.45%
Royce Quant Small-Cap Quality Value ETF
0.4%
First Trust Active Factor Small Cap ETF
0.35%
Vanguard US Multifactor ETF
0.14%
WisdomTree US SmallCap Fund
0.13%
VictoryShares Small Cap Free Cash Flow ETF
0.13%
Ver más
Cambria Micro and SmallCap Shareholder Yield ETF
Proporción1.07%
Acquirers Small and Micro Deep Value ETF
Proporción1.04%
Lattice Hartford Multifactor Small Cap ETF
Proporción0.61%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.49%
First Trust Dow Jones Select MicroCap Index Fund
Proporción0.45%
Royce Quant Small-Cap Quality Value ETF
Proporción0.4%
First Trust Active Factor Small Cap ETF
Proporción0.35%
Vanguard US Multifactor ETF
Proporción0.14%
WisdomTree US SmallCap Fund
Proporción0.13%
VictoryShares Small Cap Free Cash Flow ETF
Proporción0.13%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
